Managing Director, Tenmile
| Role | Organisation | Sources |
|---|---|---|
| CEO | Minderoo Foundation | Startup Daily |
| Executive (former) | Roche Group | Business News Australia, Brandon Capital portfolio, Brandon BioCatalyst portfolio |
| Managing Director | Tenmile | - |
Stories naming Dr Steve Burnell. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Biotech Aravax has received a US$20 million Series B commitment from Brandon Capital and Tenmile to advance its peanut allergy therapy PVX108 into Phase 2 trials.
Also Brandon Capital portfolio·Startup Daily·Startup News (WA)·Techboard·Startup Daily
Adelaide cancer biotech Carina Biotech has raised $5.4 million led by Andrew Forrest's Minderoo Foundation, with shareholders, board, management and institutional investors also participating, to advance its CAR-T colorectal cancer therapy toward clinical trials.